Home > Healthcare > Medical Devices > Surgical Devices > Intracranial Stenosis Stents Market

Intracranial Stenosis Stents Market Trends

Report ID: GMI6416
Published Date: Aug 2023
Report Format: PDF

Download Free Sample

Intracranial Stenosis Stents Market Trends

Ongoing advancements in medical technology led to the development of more sophisticated and effective intracranial stents. These innovations include improved stent designs, biocompatible materials, and better delivery systems, resulting in enhanced safety and efficacy of the stenting procedure. For instance, Wallaby/phenox introduced the pEGASUS HPC stent, featuring an innovative anti-thrombogenic HPC coating technology. The stent is specifically designed for patients with intracranial aneurysms and stenoses in intracranial atherosclerotic disease (ICAD).

The launch of this new stent marks a significant advancement in the field of neurovascular interventions and offers promising treatment options for individuals with neurological conditions. As the technology continues to evolve, it attracts greater interest from medical professionals and further fuels the demand for intracranial stenosis stents. Furthermore, the global population is aging, with a higher proportion of elderly individuals. As people age, they become more susceptible to vascular diseases and intracranial stenosis. The elderly population base often seeks medical intervention to improve their quality of life and prevent serious health issues including strokes.

For instance, according to the World Stroke Organization's 2022 report, there are over 12.2 million new stroke cases reported annually worldwide. The highest prevalence of stroke occurs in individuals aged 70 years and above, accounting for 67% of cases followed by those aged between 15 and 49 years representing 22% of cases. Consequently, the growing geriatric demographic contributes to the rising demand for intracranial stenosis stents as a means of effective treatment.

Authors: Mariam Faizullabhoy , Pratiksha Kamthe

Frequently Asked Questions (FAQ) :

Intracranial stenosis stents industry was worth USD 790 million in 2022 and is estimated to account for USD 1.3 billion by 2032 driven by the growing awareness of minimally invasive treatment options and the advancement of medical technologies.

The self-expanding stents segment garnered USD 286.3 million in revenue size in 2022 and is projected to witness high demand through 2032 owing to several advantages associated with its use such as minimally invasive deployment, accurate placement, flexibility, reduced risk of complications, and long-term stability.

The U.S. intracranial stenosis stents market generated USD 281.1 million in 2022 and is poised to witness significant growth through 2032 attributed to the high prevalence of neurological conditions, including intracranial stenosis due to factors such as an aging population and an increasing incidence of risk factors such as hypertension, diabetes, and high cholesterol.

Some of the prominent companies engaged in the global intracranial stenosis stents industry are Stryker Corporation, Medtronic plc, MicroPort Scientific Corporation, Abbott Laboratories, Terumo Corporation, Boston Scientific Corporation, Johnson & Johnson (DePuy Synthes), Penumbra, Inc., Acandis GmbH, BALT Extrusion, EndoSigma, Balt USA LLC and Phenox GmbH, among others.